United States Integrin Beta 1 Market Report 2017

December 2017 | 99 pages | ID: UEA05520E13EN
QYResearch

Abstracts

In this report, the United States Integrin Beta 1 market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Integrin Beta 1 in these regions, from 2012 to 2022 (forecast).

United States Integrin Beta 1 market competition by top manufacturers/players, with Integrin Beta 1 sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Avipero Ltd
• Clanotech AB
• Morphic Therapeutic Inc
• Strykagen Corp
• Valeant Pharmaceuticals International Inc

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• AXT-108
• C-16Y
• CLT-28643
• SAL-021
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Genetic Disorders
• Dermatology
• Cardiovascular
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Integrin Beta 1 Market Report 2017

1 INTEGRIN BETA 1 OVERVIEW

1.1 Product Overview and Scope of Integrin Beta
1.2 Classification of Integrin Beta 1 by Product Category
  1.2.1 United States Integrin Beta 1 Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Integrin Beta 1 Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 AXT-108
  1.2.4 C-16Y
  1.2.5 CLT-28643
  1.2.6 SAL-021
  1.2.7 Others
1.3 United States Integrin Beta 1 Market by Application/End Users
  1.3.1 United States Integrin Beta 1 Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Genetic Disorders
  1.3.3 Dermatology
  1.3.4 Cardiovascular
  1.3.5 Others
1.4 United States Integrin Beta 1 Market by Region
  1.4.1 United States Integrin Beta 1 Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Integrin Beta 1 Status and Prospect (2012-2022)
  1.4.3 Southwest Integrin Beta 1 Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Integrin Beta 1 Status and Prospect (2012-2022)
  1.4.5 New England Integrin Beta 1 Status and Prospect (2012-2022)
  1.4.6 The South Integrin Beta 1 Status and Prospect (2012-2022)
  1.4.7 The Midwest Integrin Beta 1 Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Integrin Beta 1 (2012-2022)
  1.5.1 United States Integrin Beta 1 Sales and Growth Rate (2012-2022)
  1.5.2 United States Integrin Beta 1 Revenue and Growth Rate (2012-2022)

2 UNITED STATES INTEGRIN BETA 1 MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Integrin Beta 1 Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Integrin Beta 1 Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Integrin Beta 1 Average Price by Players/Suppliers (2012-2017)
2.4 United States Integrin Beta 1 Market Competitive Situation and Trends
  2.4.1 United States Integrin Beta 1 Market Concentration Rate
  2.4.2 United States Integrin Beta 1 Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Integrin Beta 1 Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES INTEGRIN BETA 1 SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Integrin Beta 1 Sales and Market Share by Region (2012-2017)
3.2 United States Integrin Beta 1 Revenue and Market Share by Region (2012-2017)
3.3 United States Integrin Beta 1 Price by Region (2012-2017)

4 UNITED STATES INTEGRIN BETA 1 SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Integrin Beta 1 Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Integrin Beta 1 Revenue and Market Share by Type (2012-2017)
4.3 United States Integrin Beta 1 Price by Type (2012-2017)
4.4 United States Integrin Beta 1 Sales Growth Rate by Type (2012-2017)

5 UNITED STATES INTEGRIN BETA 1 SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Integrin Beta 1 Sales and Market Share by Application (2012-2017)
5.2 United States Integrin Beta 1 Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES INTEGRIN BETA 1 PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Avipero Ltd
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Integrin Beta 1 Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Avipero Ltd Integrin Beta 1 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Clanotech AB
  6.2.2 Integrin Beta 1 Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Clanotech AB Integrin Beta 1 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Morphic Therapeutic Inc
  6.3.2 Integrin Beta 1 Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Morphic Therapeutic Inc Integrin Beta 1 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Strykagen Corp
  6.4.2 Integrin Beta 1 Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Strykagen Corp Integrin Beta 1 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Valeant Pharmaceuticals International Inc
  6.5.2 Integrin Beta 1 Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Valeant Pharmaceuticals International Inc Integrin Beta 1 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview

7 INTEGRIN BETA 1 MANUFACTURING COST ANALYSIS

7.1 Integrin Beta 1 Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Integrin Beta

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Integrin Beta 1 Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Integrin Beta 1 Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES INTEGRIN BETA 1 MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Integrin Beta 1 Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Integrin Beta 1 Sales Volume Forecast by Type (2017-2022)
11.3 United States Integrin Beta 1 Sales Volume Forecast by Application (2017-2022)
11.4 United States Integrin Beta 1 Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Integrin Beta
Figure United States Integrin Beta 1 Market Size (K Pcs) by Type (2012-2022)
Figure United States Integrin Beta 1 Sales Volume Market Share by Type (Product Category) in 2016
Figure AXT-108 Product Picture
Figure C-16Y Product Picture
Figure CLT-28643 Product Picture
Figure SAL-021 Product Picture
Figure Others Product Picture
Figure United States Integrin Beta 1 Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Integrin Beta 1 by Application in 2016
Figure Genetic Disorders Examples
Table Key Downstream Customer in Genetic Disorders
Figure Dermatology Examples
Table Key Downstream Customer in Dermatology
Figure Cardiovascular Examples
Table Key Downstream Customer in Cardiovascular
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Integrin Beta 1 Market Size (Million USD) by Region (2012-2022)
Figure The West Integrin Beta 1 Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Integrin Beta 1 Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Integrin Beta 1 Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Integrin Beta 1 Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Integrin Beta 1 Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Integrin Beta 1 Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Integrin Beta 1 Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Integrin Beta 1 Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Integrin Beta 1 Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Integrin Beta 1 Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Integrin Beta 1 Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Integrin Beta 1 Sales Share by Players/Suppliers
Figure 2017 United States Integrin Beta 1 Sales Share by Players/Suppliers
Figure United States Integrin Beta 1 Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Integrin Beta 1 Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Integrin Beta 1 Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Integrin Beta 1 Revenue Share by Players/Suppliers
Figure 2017 United States Integrin Beta 1 Revenue Share by Players/Suppliers
Table United States Market Integrin Beta 1 Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Integrin Beta 1 Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Integrin Beta 1 Market Share of Top 3 Players/Suppliers
Figure United States Integrin Beta 1 Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Integrin Beta 1 Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Integrin Beta 1 Product Category
Table United States Integrin Beta 1 Sales (K Pcs) by Region (2012-2017)
Table United States Integrin Beta 1 Sales Share by Region (2012-2017)
Figure United States Integrin Beta 1 Sales Share by Region (2012-2017)
Figure United States Integrin Beta 1 Sales Market Share by Region in 2016
Table United States Integrin Beta 1 Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Integrin Beta 1 Revenue Share by Region (2012-2017)
Figure United States Integrin Beta 1 Revenue Market Share by Region (2012-2017)
Figure United States Integrin Beta 1 Revenue Market Share by Region in 2016
Table United States Integrin Beta 1 Price (USD/Pcs) by Region (2012-2017)
Table United States Integrin Beta 1 Sales (K Pcs) by Type (2012-2017)
Table United States Integrin Beta 1 Sales Share by Type (2012-2017)
Figure United States Integrin Beta 1 Sales Share by Type (2012-2017)
Figure United States Integrin Beta 1 Sales Market Share by Type in 2016
Table United States Integrin Beta 1 Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Integrin Beta 1 Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Integrin Beta 1 by Type (2012-2017)
Figure Revenue Market Share of Integrin Beta 1 by Type in 2016
Table United States Integrin Beta 1 Price (USD/Pcs) by Types (2012-2017)
Figure United States Integrin Beta 1 Sales Growth Rate by Type (2012-2017)
Table United States Integrin Beta 1 Sales (K Pcs) by Application (2012-2017)
Table United States Integrin Beta 1 Sales Market Share by Application (2012-2017)
Figure United States Integrin Beta 1 Sales Market Share by Application (2012-2017)
Figure United States Integrin Beta 1 Sales Market Share by Application in 2016
Table United States Integrin Beta 1 Sales Growth Rate by Application (2012-2017)
Figure United States Integrin Beta 1 Sales Growth Rate by Application (2012-2017)
Table Avipero Ltd Basic Information List
Table Avipero Ltd Integrin Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Avipero Ltd Integrin Beta 1 Sales Growth Rate (2012-2017)
Figure Avipero Ltd Integrin Beta 1 Sales Market Share in United States (2012-2017)
Figure Avipero Ltd Integrin Beta 1 Revenue Market Share in United States (2012-2017)
Table Clanotech AB Basic Information List
Table Clanotech AB Integrin Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Clanotech AB Integrin Beta 1 Sales Growth Rate (2012-2017)
Figure Clanotech AB Integrin Beta 1 Sales Market Share in United States (2012-2017)
Figure Clanotech AB Integrin Beta 1 Revenue Market Share in United States (2012-2017)
Table Morphic Therapeutic Inc Basic Information List
Table Morphic Therapeutic Inc Integrin Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Morphic Therapeutic Inc Integrin Beta 1 Sales Growth Rate (2012-2017)
Figure Morphic Therapeutic Inc Integrin Beta 1 Sales Market Share in United States (2012-2017)
Figure Morphic Therapeutic Inc Integrin Beta 1 Revenue Market Share in United States (2012-2017)
Table Strykagen Corp Basic Information List
Table Strykagen Corp Integrin Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Strykagen Corp Integrin Beta 1 Sales Growth Rate (2012-2017)
Figure Strykagen Corp Integrin Beta 1 Sales Market Share in United States (2012-2017)
Figure Strykagen Corp Integrin Beta 1 Revenue Market Share in United States (2012-2017)
Table Valeant Pharmaceuticals International Inc Basic Information List
Table Valeant Pharmaceuticals International Inc Integrin Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Valeant Pharmaceuticals International Inc Integrin Beta 1 Sales Growth Rate (2012-2017)
Figure Valeant Pharmaceuticals International Inc Integrin Beta 1 Sales Market Share in United States (2012-2017)
Figure Valeant Pharmaceuticals International Inc Integrin Beta 1 Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Integrin Beta
Figure Manufacturing Process Analysis of Integrin Beta
Figure Integrin Beta 1 Industrial Chain Analysis
Table Raw Materials Sources of Integrin Beta 1 Major Players/Suppliers in 2016
Table Major Buyers of Integrin Beta
Table Distributors/Traders List
Figure United States Integrin Beta 1 Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Integrin Beta 1 Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Integrin Beta 1 Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Integrin Beta 1 Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Integrin Beta 1 Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Integrin Beta 1 Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Integrin Beta 1 Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Integrin Beta 1 Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Integrin Beta 1 Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Integrin Beta 1 Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Integrin Beta 1 Sales Volume Share Forecast by Region (2017-2022)
Figure United States Integrin Beta 1 Sales Volume Share Forecast by Region (2017-2022)
Figure United States Integrin Beta 1 Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources